xortx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | XORTX Therapeutics Inc. |
| Description | Skip to footer Home About Overview Management Team Board of Directors Advisory Board Pipeline Overview XRx-008 for Autosomal Dominant Polycystic Kidney Di |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.208.101.55 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
xortx.com Valuation
|
US$6,312,486
Last updated: 2023-05-12 02:03:30
xortx.com has Semrush global rank of 1,676,725. xortx.com has an estimated worth of US$ 6,312,486, based on its estimated Ads revenue. xortx.com receives approximately 728,364 unique visitors each day. Its web server is located in United States, with IP address 54.208.101.55. According to SiteAdvisor, xortx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,312,486 |
| Daily Ads Revenue | US$5,827 |
| Monthly Ads Revenue | US$174,808 |
| Yearly Ads Revenue | US$2,097,688 |
| Daily Unique Visitors | 48,558 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| xortx.com. | A | 60 | IP: 54.208.101.55 |
| xortx.com. | NS | 60 | NS Record: ns1.resourcesgroup.ca. |
| xortx.com. | NS | 60 | NS Record: ns2.resourcesgroup.ca. |
| xortx.com. | MX | 60 | MX Record: 20 ALT1.ASPMX.L.GOOGLE.com. |
| xortx.com. | MX | 60 | MX Record: 20 ALT2.ASPMX.L.GOOGLE.com. |
| xortx.com. | MX | 60 | MX Record: 30 ASPMX2.GOOGLEMAIL.com. |
| xortx.com. | MX | 60 | MX Record: 80 ASPMX3.GOOGLEMAIL.com. |
| xortx.com. | MX | 60 | MX Record: 10 ASPMX.L.GOOGLE.com. |
| xortx.com. | TXT | 60 | TXT Record: google-site-verification=7fUzAkOxxP2FvmDhLSo1k4anaQv9lqdcRIokRv9aF-Y |
HtmlToTextCheckTime:2023-05-12 02:03:30
| Skip to footer Home About Overview Management Team Board of Directors Advisory Board Pipeline Overview XRx-008 for Autosomal Dominant Polycystic Kidney Disease XRx-101 for Coronavirus/COVID-19 XRX-225 for Type 2 Diabetic Nephropathy Publications Technology News & Media Press Releases Events In the News Investors Overview News & Events Presentations Company Info Financial Info Stock Data SEC Filings SEDAR Governance Contact Pioneering New Therapies for Progressive Kidney Disease We are XORTX Therapeutics, a late stage clinical pharmaceutical company dedicated to developing innovative therapies to improve the quality of life of patients with progressive kidney disease. Our programs are designed to manage aberrant purine metabolism and reduce high uric acid and slow progression of kidney disease. About our company Developing First-in-class Uric Acid Lowering Agents We have three programs, two of these programs are in clinical development and one is at an early stage of development, each |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 24 Nov 2021 08:54:51 GMT Server: Apache Location: https://www.xortx.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Wed, 24 Nov 2021 08:54:52 GMT Server: Apache X-Frame-Options: SAMEORIGIN Strict-Transport-Security: max-age=31536000; X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Feature-Policy: microphone 'none'; camera 'none'; geolocation 'none'; screen-wake-lock 'none'; Referrer-Policy: strict-origin-when-cross-origin Content-Security-Policy: default-src *.gstatic.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; script-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com browser-update.org cdn.sajari.com cdn.sajari.net jsonapi.sajari.net *.hcaptcha.com hcaptcha.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; connect-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com browser-update.org cdn.sajari.com cdn.sajari.net jsonapi.sajari.net *.hcaptcha.com hcaptcha.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; style-src fonts.googleapis.com *.gstatic.com *.hcaptcha.com hcaptcha.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net 'unsafe-inline'; font-src cdnjs.cloudflare.com/ajax/libs/font-awesome/ fonts.googleapis.com *.gstatic.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; img-src www.globenewswire.com ml.globenewswire.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; frame-src *.google.com youtube.com youtube-nocookie.com vimeo.com *.hcaptcha.com hcaptcha.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; object-src *.gstatic.com ir.stockpr.com www.xortx.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; Content-Type: text/html; charset=UTF-8 |
xortx.com Whois Information
Domain Name: XORTX.COM Registry Domain ID: 1778610985_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-06T17:20:15Z Creation Date: 2013-02-05T22:23:09Z Registry Expiry Date: 2022-02-05T22:23:09Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.RESOURCESGROUP.CA Name Server: NS2.RESOURCESGROUP.CA DNSSEC: unsigned >>> Last update of whois database: 2021-11-24T08:36:56Z <<< |